Found: 4
Select item for more details and to access through your institution.
Novel Small‐Molecular Ligands for Prolyl Oligopeptidase to Combat Tauopathies.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 21, p. 1, doi. 10.1002/alz.076392
- By:
- Publication type:
- Article
A prolyl oligopeptidase inhibitor reduces tau pathology in cellular models and in mice with tauopathy.
- Published in:
- Science Translational Medicine, 2023, v. 15, n. 691, p. 1, doi. 10.1126/scitranslmed.abq2915
- By:
- Publication type:
- Article
Prolyl oligopeptidase inhibition reduces alpha-synuclein aggregation in a cellular model of multiple system atrophy.
- Published in:
- Journal of Cellular & Molecular Medicine, 2021, v. 25, n. 20, p. 9634, doi. 10.1111/jcmm.16910
- By:
- Publication type:
- Article
Deletion or inhibition of prolyl oligopeptidase blocks lithium‐induced phosphorylation of GSK3b and Akt by activation of protein phosphatase 2A.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2021, v. 129, n. 4, p. 287, doi. 10.1111/bcpt.13632
- By:
- Publication type:
- Article